Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Œsophage » Néoplasie

17. Juin 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Troubles de la motilité

Écriture:

Page 1 de 1952


	Articles 1 - 20 / 39034

	Development and internal validation of a prognostic model for esophageal cancer liver metastases using the Surveillance, Epidemiology, and End Results database. J Thorac Dis Jiang J, Zeng Y, Wan J, Zhang L, Zhang Z, Bai R, Wang C, Lin F. PMID: 42306725 [PubMed - in process]
	Machine learning to predict distant metastasis risk and prognostic analysis in T1-2 esophageal cancer: a study based on the SEER database. J Thorac Dis Shi P, Yang P, Wu H, Lian C, Zhu B, Li Y. PMID: 42306722 [PubMed - in process]
	Narrative review: clinical application and challenges of circulating tumor DNA in treatment response evaluation and prognostic prediction for esophageal cancer. J Thorac Dis Gu R, Liu T, Jin H, Wang X. PMID: 42306701 [PubMed - in process]
	Cardiovascular and cerebrovascular related death among patients with esophageal cancer: an international multicenter study. J Thorac Dis Ai J, Zhao L, Li Y, Shi G, Zhang Z, Li X, Wang Y. PMID: 42306675 [PubMed - in process]
	Clinical Analysis of Rotational-Translational Error Coupling in 3DoF Versus 6DoF CBCT Couch Corrections:A Cross-Sectional Study. Technol Cancer Res Treat Yi L, Li K, Zhong R, Yue H, Lu Z. PMID: 42305096 [PubMed - indexed for MEDLINE]
	Efficacy of Combination Therapy of Local Triamcinolone Injection and Oral Prednisolone Administration for Stricture Prevention After Extensive Non-Circumferential Esophageal Endoscopic Submucosal Dissection. Dig Endosc Kadota T, Sasabe M, Yamashita H, Inaba A, Sunakawa H, Nakajo K, Shinmura K, Yano T. PMID: 42304968 [PubMed - indexed for MEDLINE]
	Role of spectral CT in quantitative evaluation of pathologic response to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma: a pilot study. J Transl Med Zheng H, Zhu Y, Li M, Zhang Q, Wei X, Chen X, Ren W, Liu S. PMID: 42304386 [PubMed - as supplied by publisher]
	Ultrasound-, CT-, and MRI-based logistic regression models for the diagnosis of supraclavicular lymph node metastasis in esophageal squamous cell carcinoma. Eur J Radiol Du J, Huang Y, Han B, Li L, Zhang R, Zhou Y, Wang Z, Zhao K, Chu F, Bai B, Zhang H, Wang Z, Li W, Li J, Wang M, Li Q, Qu J. PMID: 42302436 [PubMed - as supplied by publisher]
	Retraction: Secular Trends in Gastric and Esophageal Cancer Attributable to Dietary Carcinogens From 1990 to 2019 and Projections Until 2044 in China: Population-Based Study. JMIR Public Health Surveill JMIR Publications Editorial Office. PMID: 42302259 [PubMed - in process]
	Corrigendum to "The efficacy of thoracic duct ligation for post-esophagectomy chylothorax in esophageal cancer: a nationwide inpatient cohort study" [Surg. Oncology 63 (2025) 102279]. Surg Oncol Shigeno T, Okuno K, Ogo T, Tanioka T, Kawada K, Fujiwara H, Kagawa H, Tokunaga M, Fushimi K, Kinugasa Y. PMID: 42296696 [PubMed - as supplied by publisher]
	TNM staging of esophageal cancer using fine-tuned pathology foundation models and multiple instance learning. Front Oncol Cao J, Wang J. PMID: 42294306 [PubMed]
	Phase II Trial of First-Line Durvalumab and Chemotherapy in Patients With Extra-Pulmonary Small Cell Carcinoma. JTO Clin Res Rep Kok PS, Chan B, Aberoumoud M, Zhang A, O'Byrne K, Thavaneswaran S, Lin F, Kansara M, Corpuz T, Wheeler P, Simes RJ, Thomas D, Lee CK. PMID: 42293288 [PubMed]
	Efficacy and safety of neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced esophagogastric junction or gastric cancer: a systematic review and meta analysis. Front Immunol Ma X, Guo W, Sun J, Liang Y, Yao C, Chi Y, Chi Z, Li T, Wang R, Gao R, Gao Y, Zhang Z, Miao M, Shang K, Gao C. PMID: 42292472 [PubMed - indexed for MEDLINE]
	Definitive chemoradiotherapy plus immune checkpoint inhibitors for locally advanced unresectable esophageal squamous cell carcinoma: survival and progression patterns in a propensity-matched cohort. Front Immunol Lin Z, Shen Y, Li Q, Liu D, Chen J, Cai S, Lin Z, Chen M, Lin Y, Chen J, Xu Y. PMID: 42292446 [PubMed - indexed for MEDLINE]
	Efficacy and safety of thymosin combined with anticancer therapy for esophageal cancer: a systematic review and meta-analysis of randomized controlled trials. Front Immunol Sun T, Zhao R, Zhang C, Shan X, Zhang Y, Zheng Y. PMID: 42292434 [PubMed - indexed for MEDLINE]
	Real-world outcomes of ipilimumab plus nivolumab in esophageal squamous cell carcinoma: a multi-institutional large cohort study. Cancer Immunol Immunother Hara S, Makino T, Nakai S, Momose K, Yamashita K, Tanaka K, Satoh T, Sugimura K, Kawabata R, Takeno A, Motoori M, Yamasaki M, Miyata H, Kimura Y, Yasuda T, Eguchi H, Doki Y. PMID: 42289036 [PubMed - as supplied by publisher]
	A migration/invasion-related prognostic signature identifies and functionally validates SLC25A5 as a hub associated with spliceosome programs and invasive phenotypes in esophageal squamous cell carcinoma. Funct Integr Genomics Guo J, Si G, Si F. PMID: 42287557 [PubMed - indexed for MEDLINE]
	The oral microbiome is associated with the diagnosis, prognosis and radiotherapy sensitivity of esophageal cancer. J Transl Med Li L, Li L, Yang Y, Wang C, Lan Z, Liu J, Zhu X, Zhao C, Yang M, Ma Y, Liu Y, Ren Z. PMID: 42286580 [PubMed - indexed for MEDLINE]
	Study on the Cytotoxic Effects, Apoptosis Induction, Treatment Resistance, and Inflammation Caused by a Gold(III) Complex Containing 3,4-diaminobenzophenone and 2,3-butanedione Monoxime on the Esophageal Cancer Cell Line KYSE-30. Curr Mol Med Lu X, Majd MH, Shahraki S, Li S. PMID: 42283168 [PubMed - as supplied by publisher]
	Global patterns of upper gastrointestinal cancer incidence by subtype and subsite in 2022: a population-based study. J Natl Cancer Cent Zheng Y, Tan N, Teng Y, Li T, Wang J, Wu Y, Li Q, Cao M, He S, Zuo T, Xia C, Chen W. PMID: 42282122 [PubMed]

Articles 1 - 20 / 39034

Page 1 de 1952



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité